NextCure NXTC
NASDAQ NXTC
$6.29 +0.04 (+0.64%)
At close: Aug 21, 2026 · 4:00 PM EDT

NextCure (NXTC) Change in Account Payables (2018 - 2026)

NextCure (NXTC) posted quarterly Change in Account Payables of $1.1 million for Q1 2026, up 140.47% year-over-year from $440394.6 in Q1 2025, and up 378.68% quarter-over-quarter from -$380000.0 in Q4 2025.

NextCure (NXTC) Change in Account Payables (2018 - 2026) Analysis & Trends

NextCure's Change in Account Payables history runs 9 years deep, the most recent figure standing at $1.1 million for Q1 2026.

  • In Q1 2026, Change in Account Payables rose 140.47% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $334000.0 (up 119.03% YoY), while the FY2025 annual figure was -$3.3 million, down 210.55% from the prior year.
  • Change in Account Payables for Q1 2026 stood at $1.1 million, up from -$380000.0 in the prior quarter.
  • The five-year high for Change in Account Payables was $2.4 million in Q4 2022, with the low at -$2.6 million in Q1 2025.
  • The 5-year median for Change in Account Payables is -$192000.0 (2025), against an average of $66352.9.
  • Peak annual rise in Change in Account Payables reached 739.71% in 2024, while the deepest fall reached 592.89% in 2024.
  • NextCure's Change in Account Payables stood at $2.4 million in 2022, then tumbled by 111.23% to -$272000.0 in 2023, then soared by 739.71% to $1.7 million in 2024, then tumbled by 121.84% to -$380000.0 in 2025, then surged by 378.68% to $1.1 million in 2026.
  • Business Quant data shows NXTC's Change in Account Payables at $1.1 million in Q1 2026, -$380000.0 in Q4 2025, and -$153000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -8.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 37.53 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 NextCure 33.72 Mn 33.72 Mn - -492,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -492,000.00
Jun 30, 2026 -492,000.00
Mar 31, 2026 1.06 Mn
Mar 31, 2026 1.06 Mn
Dec 31, 2025 -380,000.00
Dec 31, 2025 -380,000.00
Sep 30, 2025 -153,000.00
Sep 30, 2025 -153,000.00
Jun 30, 2025 -192,000.00
Jun 30, 2025 -192,000.00
Mar 31, 2025 -2.62 Mn
Mar 31, 2025 -2.62 Mn
Dec 31, 2024 1.74 Mn
Dec 31, 2024 1.74 Mn
Sep 30, 2024 -1.46 Mn
Sep 30, 2024 -1.46 Mn
Jun 30, 2024 584,000.00
Jun 30, 2024 584,000.00
Mar 31, 2024 2.16 Mn
Mar 31, 2024 2.16 Mn